Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
18F-MFBG Imaging in Neural Crest Tumors
NCT05069220Phase 1Recruiting
- Sponsor
- Peking Union Medical College Hospital
- Start
- Sep 2021
- Primary completion
- Sep 2025
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial, sponsored by Peking Union Medical College Hospital. Primary endpoint: Evaluation of diagnostic performance of 18F-MFBG PET in different regions in metastatic neural crest tumor at 1 year. Started Sep 2021; status: recruiting.
Beyond the preview
Go deeper on NCT05069220.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05069220.